Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 31 recruiting now full pipeline #125 of 28,707 conditions

Schizoaffective Disorder: full-pipeline trial registry

31 of 105 indexed Schizoaffective Disorder trials are currently recruiting.

Corpus placement: #125 of 28,707 conditions by registered trial count.

105 US clinical trials · 31 currently recruiting · #125 of 28,707 conditions by registered trial count

Schizoaffective Disorder: 105 US clinical trials tracked, 31 recruiting.

Schizoaffective Disorder is the subject of 105 registered US clinical trials on ClinicalTrials.gov, 31 of them currently open to new participants. 20 are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most active sponsor is University of Maryland, Baltimore, running 8 of these trials.

Enrollment posture brief

Registry condition schizoaffective-disorder

OPEN 31 | RECR 30% | LATE 20 | EARLY 21 | RANK #125 | SPON 8

Nearest open-share peer: Emphysema (30% recruiting · 27 trials)

Autism46.7%Cognitive Impairment43.4%Migraine38.1%Hematopoietic and Lymphoid C33.3%Schizoaffective Disorder (th…30%
Open-enrollment share among volume-matched conditions near Schizoaffective Disorder

Schizoaffective Disorder lists 31 open slots (30% of 105 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Schizoaffective Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Schizoaffective Disorder is recruiting below its size-band peers.

    31 of 105 indexed trials (29.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Schizoaffective Disorder trials is spread across many organizations.

    University of Maryland, Baltimore accounts for 8 of 105 trials (7.6%). 56 distinct sponsors appear on at least one study for this condition label.

  3. Most Schizoaffective Disorder trials plan to enrol fewer than 100 people.

    Median target enrolment is 67 among the 104 trials that report a genuine target (sentinel values excluded). 66 of those (63.5%) plan for fewer than 100 participants.

  4. Schizoaffective Disorder research is mostly interventional.

    99 interventional and 6 observational studies make up this index (94.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 110Phase 211Phase 34Phase 416

Phase Distribution

PhaseTrial count
Phase 1 10
Phase 2 11
Phase 3 4
Phase 4 16

Named interventions

Most-linked intervention names on Schizoaffective Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
14 trials
D-serine Drug
2 trials
Cognitive Remediation Behavioral
2 trials
Cognitive training Behavioral
2 trials
Placebo Other
2 trials
CRT and Social Cognition Behavioral
1 trials
Computerized Cognitive Skill Training Behavioral
1 trials
Enhanced treatment as usual (e-TAU) Behavioral
1 trials

US sites by state

Facility locations filed on Schizoaffective Disorder trials. A trial with sites in several states counts in each.

California 29 trials
New York 19 trials
Maryland 16 trials
Massachusetts 16 trials
Texas 11 trials
Pennsylvania 10 trials
Georgia 10 trials
Illinois 9 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Schizoaffective Disorder page

105 registered trials, 31 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Schizoaffective Disorder condition card totals 105 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.